The expression of programmed death ligand 1 (PD-L1) on the surface of tumor cells and its interaction with programmed cell death protein 1 (PD-1) on tumor-infiltrating lymphocytes play a role in suppressing antitumor immune responses. This evidence concerns the gene PDCD1 and neoplasm.